Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Advantagene Inc.

www.advantagene.com

Latest From Advantagene Inc.

Finance Watch: Arteaus Comes Full Circle As Investors Monetize Emgality Royalties

Arteaus sells royalty stream from Lilly's Emgality giving investors a $260m payday. Also, Pfizer spin-out SpringWorks nabs another $125m, Arch Oncology and Prevail Therapeutics close $50m Series B rounds, and Karuna's recent financing grows to $80m.

Financing StartUps and SMEs

PROSPECTs Futile For Bavarian Nordic's Prostvac Cancer Vaccine

The Phase III PROSPECT study's data monitoring committee decides against continuing after interim analysis. The fall-out could hit Bavarian Nordic’s CV301 too.

Cancer Clinical Trials

Janssen's Zytiga Shines At ASCO But Prostate Cancer Pipeline Progress May Dampen Impact

Janssen reported treatment altering Phase III data at ASCO 2017 for a new Zytiga combination targeting hormone-naïve metastatic prostate cancer patients – but the triple regimen's relevance might be short-lived as momentum builds in the late-stage pipeline.

Clinical Trials Cancer

Prostate Cancer Vaccines: What’s In The Pipeline?

The sector still attracts the attention of clinical investigators and the pharmaceutical industry, despite disappointing results from another clinical-stage candidate.

Commercial Market Intelligence
See All

Company Information

  • Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
    • Large Molecule
  • Pharmaceuticals
    • Drug Delivery
      • Macromolecule
    • Vaccines
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Advantagene Inc.
  • Senior Management
  • Estuardo Aguilar-Cordova, MD, PhD, CEO
    Laura Aguilar, MD, PhD, CMO
    Stephen Rocamboli, CBO
    Brian Guzik, PhD, Sr. Dir., Bus. Dev.
  • Contact Info
  • Advantagene Inc.
    Phone: (617) 916-5445
    440 Lexington St.
    Auburndale, MA 02466
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register